Diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable treatments such as ...

On June 7, over 350 riders gathered in Scottsville for the American Diabetes Association (ADA)’s 2025 Tour de Cure: Finger ...

The combination of once-weekly cagrilintide 2.4 mg and semaglutide 2.4 mg conferred greater weight loss at 68 weeks compared with placebo in patients with overweight or obesity with or without ...

A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

The first diabetes and obesity pill that is similar to Ozempic — but in tablet form — may actually outperform the popular ...

The data were featured in an oral presentation at the American Diabetes Association (ADA) annual conference in Chicago as part of the symposium, “Innovation and Progress in Stem Cell-Derived ...

CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...